Athena Technology Acquisition Corp. II (ATEK): Nasdaq/NYSE listing notice — Athena Tech Acquisition Corp. II receives NYSE American noncompliance notice for late 10-K

Athena Technology Acquisition Corp. II

Received NYSE American notice on April 17, 2024 for failure to timely file 2023 Form 10-K by April 16, 2024.
Intends to file delinquent report in near future but no estimated cure date provided.
Notice has no immediate effect on listing or trading of Class A common stock on NYSE American.
No assurance that the company will ultimately regain or remain in compliance with listing standards.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Athena Technology Acquisition Corp. II received a nyse_american noncompliance notice notice regarding late filing.

Exchange: nyse american
Notice: noncompliance notice
Deficiency: late filing

Exact text from the filing

April 17, 2024, Athena Technology Acquisition Corp. II, a Delaware corporation (the “Company”), received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”) due to the failure to timely file the Company’s Form 10-K for the year ended December 31, 2023 (the “Delinquent Report”) by the filing due date of April 16, 2024 (the “Filing Delinquency”). The Company intends to file the Delinquent Report in the near future, however

View on SEC.gov

Browse all listing & compliance notices →

Athena Technology Acquisition Corp. II filing history →

Source: SEC EDGAR

accession 0001213900-24-035820

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.